Skip to main content
OpenTrials

Clinical trial condition

Bone Metastases in Men With Hormone-Refractory Prostate Cancer

Explore clinical trials studying Bone Metastases in Men With Hormone-Refractory Prostate Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Bone Metastases in Men With Hormone-Refractory Prostate Cancer trial results

Completed

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

NCT01419717

Conditions
Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, Breast Diseases, +13 more
Locations
  • Research Site Capital Federal, Buenos Aires, Argentina
  • Research Site Quilmes, Buenos Aires, Argentina
  • Research Site Córdoba, Córdoba Province, Argentina
  • Research Site Rosario, Santa Fe Province, Argentina
View all 64 locations
View Trial Details
Completed

Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only

NCT00950911

Conditions
Blood Protein Disorders, Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, +28 more
Locations
  • Research Site Jindřichův Hradec, Czechia
  • Research Site Kroměříž, Czechia
  • Research Site Olomouc, Czechia
  • Research Site Prague, Czechia
View all 17 locations
View Trial Details

Related conditions